Media Zoom
SK bioscience acquires approval for typhoid conjugate vaccine
2022.05.17
South Korea-based SK Bioscience has secured another approval for in-house vaccine.
SK Bioscience obtained an export license for the typhoid vaccine ´Skytyphoid Multi-Zoo (task name NBP618, hereafter referred to as Skytyphoid)´ jointly developed with IVI (International Vaccine Institute) for domestic food and drug safety.